Evolution of the Average Target: Northwest Biotherapeutics, Inc.

Evolution of the Target Price: Northwest Biotherapeutics, Inc.

Changes in Analyst Recommendations: Northwest Biotherapeutics, Inc.

79d093ccb36249830e19f.VCTRp2k_wOUCzN-TiX1-YcRVh7JMtnVqevL8j7kjdA8.BhSy_UR4kq5XroCn6kgEWKgW0P0G_CoFDrWm_oBWRUYMXYXxOmfzjGCHkg~3bee7c67d2eceeb76c5cffaa067c0dd5

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+15.62%
+22.39%
+9.04%
+69.15%
+18.27%
+6.59%
+20.98%
-8.02%
+36.13%
Average +21.13%
Weighted average by Cap. +21.07%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.1525USD
Average target price
1.000USD
Spread / Average Target
+555.74%
High Price Target
1.000USD
Spread / Highest target
+555.74%
Low Price Target
1.000USD
Spread / Lowest Target
+555.74%

Analyst Consensus Detail

Consensus revision (last 18 months)

  1. Stock Market
  2. Stocks
  3. NWBO Stock
  4. NBYB Stock
  5. Consensus Northwest Biotherapeutics, Inc.